Gen-U Medical Research And Diagnostic Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 30-12-2024
- Paid Up Capital ₹ 0.10 M
as on 30-12-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 72.77%
(FY 2022)
- Ebitda 72.77%
(FY 2022)
- Net Worth -255.15%
(FY 2022)
- Total Assets 615.95%
(FY 2022)
About Gen-U Medical Research And Diagnostic Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pangam Ramesh and Sree Pangam serve as directors at the Company.
- CIN/LLPIN
U85110TG2020PTC144387
- Company No.
144387
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Sep 2020
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gen-U Medical Research And Diagnostic Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pangam Ramesh  | Director | 30-Sep-2020 | Current |
| Sree Pangam | Director | 30-Sep-2020 | Current |
Financial Performance of Gen-U Medical Research And Diagnostic Laboratories.
Gen-U Medical Research And Diagnostic Laboratories Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 72.77% increase in profit. The company's net worth observed a substantial decline by a decrease of 255.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gen-U Medical Research And Diagnostic Laboratories?
Unlock access to Gen-U Medical Research And Diagnostic Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gen-U Medical Research And Diagnostic Laboratories?
Gen-U Medical Research And Diagnostic Laboratories has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gen-U Medical Research And Diagnostic Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gen-U Medical Research And Diagnostic Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.